Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review

Detalhes bibliográficos
Autor(a) principal: Manna, Camila Alves
Data de Publicação: 2023
Outros Autores: Costa, Monique, Alves Filho, Carlos Alberto, Beneti, Igor Mariotto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: MedNEXT Journal of Medical and Health Sciences
Texto Completo: https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/278
Resumo: Introduction: In the context of temporomandibular disorders (TMD), temporomandibular joint osteoarthritis (TMJOA) is a common disease in the oral and maxillofacial regions, as well as being the most severe type. The incidence of TMD is high, affecting approximately 5%-12% of the population. There is evidence for the potential superiority of intra-articular platelet-rich plasma (PRP) injections in patients with TMJOA. Objective: This study aimed to carry out a systematic review to highlight the main clinical outcomes of the minimally invasive treatment of osteoarthritis of the temporomandibular joint through the injectable use of platelet-rich plasma. Methods: The research and development of the work were carried out from December 2022 to March 2023 in the Scopus, PubMed, Science Direct, and Scielo databases, using scientific articles from 2011 to 2022, following the PRISMA rules. The quality of the studies was based on the GRADE instrument and the risk of bias by the Cochrane instrument (Funnel Plot). Results and Conclusion: It was found 134 studies that underwent eligibility analysis. The final sample had 48 eligible studies and only 25 studies were described in the systematic review. Most studies showed homogeneity in their results, with X2 =91.2% >50%, with p<0.05. The symmetrical funnel plot did not suggest a risk of bias among studies with small sample sizes. Based on the objective of the present study, important clinical outcomes of the treatment of osteoarthritis of the temporomandibular joint were evidenced through the injectable use of platelet-rich plasma, alone or in combination with other types of treatment. However, it was observed that despite the extensive literature on the use of PRP in the treatment of joint disorders, its application in TMD is still largely unexplored.
id FACERES-1_d2bc74b325529cf49ea44753bf108dd3
oai_identifier_str oai:ojs2.mednext.zotarellifilhoscientificworks.com:article/278
network_acronym_str FACERES-1
network_name_str MedNEXT Journal of Medical and Health Sciences
repository_id_str
spelling Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic reviewTemporomandibular disordersTemporomandibular joint osteoarthritisClinical symptomsPlatelet-rich plasmaIntroduction: In the context of temporomandibular disorders (TMD), temporomandibular joint osteoarthritis (TMJOA) is a common disease in the oral and maxillofacial regions, as well as being the most severe type. The incidence of TMD is high, affecting approximately 5%-12% of the population. There is evidence for the potential superiority of intra-articular platelet-rich plasma (PRP) injections in patients with TMJOA. Objective: This study aimed to carry out a systematic review to highlight the main clinical outcomes of the minimally invasive treatment of osteoarthritis of the temporomandibular joint through the injectable use of platelet-rich plasma. Methods: The research and development of the work were carried out from December 2022 to March 2023 in the Scopus, PubMed, Science Direct, and Scielo databases, using scientific articles from 2011 to 2022, following the PRISMA rules. The quality of the studies was based on the GRADE instrument and the risk of bias by the Cochrane instrument (Funnel Plot). Results and Conclusion: It was found 134 studies that underwent eligibility analysis. The final sample had 48 eligible studies and only 25 studies were described in the systematic review. Most studies showed homogeneity in their results, with X2 =91.2% >50%, with p<0.05. The symmetrical funnel plot did not suggest a risk of bias among studies with small sample sizes. Based on the objective of the present study, important clinical outcomes of the treatment of osteoarthritis of the temporomandibular joint were evidenced through the injectable use of platelet-rich plasma, alone or in combination with other types of treatment. However, it was observed that despite the extensive literature on the use of PRP in the treatment of joint disorders, its application in TMD is still largely unexplored.MetaScience Press2023-04-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/27810.54448/mdnt23S206MedNEXT Journal of Medical and Health Sciences; Vol. 4 No. S2 (2023): MedNEXT - Supplement 2 - March 2023MedNEXT Journal of Medical and Health Sciences; v. 4 n. S2 (2023): MedNEXT - Supplement 2 - March 20232763-567810.54448/mdnt23S2reponame:MedNEXT Journal of Medical and Health Sciencesinstname:Faculdade de Medicina em São José do Rio Preto (Faceres)instacron:FACERESenghttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/278/262Copyright (c) 2023 Camila Alves Manna, Monique Costa, Carlos Alberto Alves Filho, Igor Mariotto Benetihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessManna, Camila AlvesCosta, MoniqueAlves Filho, Carlos AlbertoBeneti, Igor Mariotto2024-01-23T15:24:19Zoai:ojs2.mednext.zotarellifilhoscientificworks.com:article/278Revistahttps://mednext.zotarellifilhoscientificworks.com/index.php/mednextPUBhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/oaimednextjmhs@zotarellifilhoscientificworks.com2763-56782763-5678opendoar:2024-01-23T15:24:19MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres)false
dc.title.none.fl_str_mv Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
title Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
spellingShingle Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
Manna, Camila Alves
Temporomandibular disorders
Temporomandibular joint osteoarthritis
Clinical symptoms
Platelet-rich plasma
title_short Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
title_full Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
title_fullStr Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
title_full_unstemmed Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
title_sort Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review
author Manna, Camila Alves
author_facet Manna, Camila Alves
Costa, Monique
Alves Filho, Carlos Alberto
Beneti, Igor Mariotto
author_role author
author2 Costa, Monique
Alves Filho, Carlos Alberto
Beneti, Igor Mariotto
author2_role author
author
author
dc.contributor.author.fl_str_mv Manna, Camila Alves
Costa, Monique
Alves Filho, Carlos Alberto
Beneti, Igor Mariotto
dc.subject.por.fl_str_mv Temporomandibular disorders
Temporomandibular joint osteoarthritis
Clinical symptoms
Platelet-rich plasma
topic Temporomandibular disorders
Temporomandibular joint osteoarthritis
Clinical symptoms
Platelet-rich plasma
description Introduction: In the context of temporomandibular disorders (TMD), temporomandibular joint osteoarthritis (TMJOA) is a common disease in the oral and maxillofacial regions, as well as being the most severe type. The incidence of TMD is high, affecting approximately 5%-12% of the population. There is evidence for the potential superiority of intra-articular platelet-rich plasma (PRP) injections in patients with TMJOA. Objective: This study aimed to carry out a systematic review to highlight the main clinical outcomes of the minimally invasive treatment of osteoarthritis of the temporomandibular joint through the injectable use of platelet-rich plasma. Methods: The research and development of the work were carried out from December 2022 to March 2023 in the Scopus, PubMed, Science Direct, and Scielo databases, using scientific articles from 2011 to 2022, following the PRISMA rules. The quality of the studies was based on the GRADE instrument and the risk of bias by the Cochrane instrument (Funnel Plot). Results and Conclusion: It was found 134 studies that underwent eligibility analysis. The final sample had 48 eligible studies and only 25 studies were described in the systematic review. Most studies showed homogeneity in their results, with X2 =91.2% >50%, with p<0.05. The symmetrical funnel plot did not suggest a risk of bias among studies with small sample sizes. Based on the objective of the present study, important clinical outcomes of the treatment of osteoarthritis of the temporomandibular joint were evidenced through the injectable use of platelet-rich plasma, alone or in combination with other types of treatment. However, it was observed that despite the extensive literature on the use of PRP in the treatment of joint disorders, its application in TMD is still largely unexplored.
publishDate 2023
dc.date.none.fl_str_mv 2023-04-16
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/other
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/278
10.54448/mdnt23S206
url https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/278
identifier_str_mv 10.54448/mdnt23S206
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/278/262
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MetaScience Press
publisher.none.fl_str_mv MetaScience Press
dc.source.none.fl_str_mv MedNEXT Journal of Medical and Health Sciences; Vol. 4 No. S2 (2023): MedNEXT - Supplement 2 - March 2023
MedNEXT Journal of Medical and Health Sciences; v. 4 n. S2 (2023): MedNEXT - Supplement 2 - March 2023
2763-5678
10.54448/mdnt23S2
reponame:MedNEXT Journal of Medical and Health Sciences
instname:Faculdade de Medicina em São José do Rio Preto (Faceres)
instacron:FACERES
instname_str Faculdade de Medicina em São José do Rio Preto (Faceres)
instacron_str FACERES
institution FACERES
reponame_str MedNEXT Journal of Medical and Health Sciences
collection MedNEXT Journal of Medical and Health Sciences
repository.name.fl_str_mv MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres)
repository.mail.fl_str_mv mednextjmhs@zotarellifilhoscientificworks.com
_version_ 1796798218217979904